Morgan Stanley’s SunLink Health Systems SSY Stock Holding History

Morgan Stanley’s Portfolio SSY Stock Details SSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2	Closed	–	–	7962
2022 Q1	$0	Buy	+2	New	+$3	﹤0.01%	8110

Other funds holding SSY

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's SSY Position: Q2 2022 in Review

Morgan Stanley sold out of SunLink Health Systems (SSY) in Q2 2022, closing a stake of 2 shares.

Morgan Stanley first reported a position in SSY in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 14 funds tracked by Wall St. Rank hold SSY as of Q2 2022.

Morgan Stanley reported no remaining SunLink Health Systems position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 2 SunLink Health Systems shares in Q2 2022.
Morgan Stanley first reported a position in SunLink Health Systems in Q1 2022 and held it in 1 quarter.
Morgan Stanley's SunLink Health Systems position peaked at $0 in Q1 2022.
14 funds tracked by Wall St. Rank held SunLink Health Systems as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.